Circulation
Audio Summaries

Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association

Jul 9, 2026

This scientific statement from the American Heart Association addresses the unique considerations and challenges of exercise training in high-risk populations, such as those with frailty or advanced heart conditions. The authors aim to identify the barriers to participation, necessary modifications to exercise programs, and the potential benefits of tailored interventions, highlighting the need for further research to develop effective, patient-centered exercise regimens for these groups. Ultimately, the statement seeks to enhance the safety and efficacy of exercise training in populations that may not benefit from traditional approaches.

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association

Jul 8, 2026

The authors aim to address the challenges of managing polypharmacy in patients with cardiovascular disease by providing guidance on deprescribing strategies applicable across different age groups. They highlight the prevalence and adverse outcomes associated with polypharmacy, emphasizing the need for tailored approaches that involve clinical cues, validated tools, and collaborative decision-making among healthcare teams. This scientific statement seeks to fill the existing gaps in the literature regarding effective deprescribing practices for both cardiovascular and non-cardiovascular medications.

Cardiovascular Risk Reduction With GLP-1 RA Drugs

Jul 6, 2026

This paper reviews the cardiovascular risk reduction associated with GLP-1 receptor agonists (RAs), originally developed for type 2 diabetes management. The authors aim to elucidate how these agents not only improve glycemic control but also confer significant cardiovascular benefits, including reductions in major adverse events across various populations. Additionally, the paper discusses the potential of emerging therapies that target multiple incretin pathways to further enhance these cardiovascular outcomes.

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)

Jun 29, 2026

The authors aim to establish a standardized definition and classification system for heart failure (HF) to address the challenges posed by subjective and ambiguous terminology that hinder research and prevention efforts. The Second Universal Definition of Heart Failure proposes a new framework that categorizes HF based on ejection fraction and emphasizes the importance of social determinants and geographic variations in HF risk and outcomes. This consensus document seeks to enhance prevention, early detection, and management of HF globally, ultimately improving patient care and cardiovascular health.

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry

Jun 26, 2026

The authors aimed to assess the quality of care for patients with aortic stenosis (AS) through the American Heart Association Target: AS registry, focusing on timely diagnosis and treatment. They found that while timely diagnosis improved from 54% to 61% between 2023 and 2024, significant gaps remained in symptom assessment and multimodality testing. The study highlights the need for improvements in the evaluation and management processes for AS to enhance patient outcomes.

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association

Jun 24, 2026

This scientific statement from the American Heart Association addresses the challenges of defining and managing heart failure during the perinatal period, a condition that remains poorly understood despite its potential prevalence. The authors emphasize the need for improved diagnostic criteria, standardized definitions, and effective screening tools to enhance recognition and treatment of heart failure in pregnant and postpartum individuals. They advocate for future research to include these populations in heart failure studies and to develop interventions aimed at early detection and better maternal health outcomes.

Challenges and Future Trends in Large Vessel Vasculitis

Jun 22, 2026

The authors aim to address the challenges and future trends in the diagnosis and management of large vessel vasculitis (LVV), specifically giant cell arteritis and Takayasu arteritis. They highlight the complexities of LVV's pathogenesis, the difficulties in diagnosis due to nonspecific symptoms, and the need for advanced imaging and targeted therapies to improve patient outcomes. The review seeks to enhance understanding of LVV's mechanisms and management strategies, particularly regarding cardiovascular complications associated with the disease and its treatment.

Consumption of Fructose-Containing Food and Beverage Sources in Childhood Through to Adulthood and Risk of Hypertension: A Prospective Cohort Study

Jun 22, 2026

This study investigates the relationship between the consumption of fructose-containing foods and beverages, particularly sugar-sweetened beverages (SSBs) and fruit juices, and the risk of developing hypertension from childhood to adulthood. The findings indicate that high intakes of SSBs and fruit juice are associated with an increased risk of hypertension, while whole fruit consumption does not show a similar association. The authors suggest that reducing SSB and fruit juice intake, starting in childhood, may help mitigate hypertension risk.

Perioperative Anemia and Patient Blood Management in Cardiac Surgery: A Scientific Statement From the American Heart Association

Jun 22, 2026

This scientific statement from the American Heart Association addresses the significant impact of perioperative anemia and blood management on outcomes in cardiac surgery. The authors aim to evaluate the prevalence and causes of preoperative anemia, particularly iron deficiency, and to discuss effective strategies for blood conservation and management during surgery. By highlighting recent research and identifying challenges in this area, the statement seeks to improve patient outcomes and resource utilization in cardiac surgical settings.

Contrastive Machine Learning to Quantify Hypertensive Multiorgan Damage and Identify New Disease Phenotypes: A Multinational Multimodal Study

Jun 21, 2026

The authors aimed to develop a novel machine learning approach to quantify multiorgan damage associated with hypertension and identify distinct disease phenotypes. By analyzing data from over 27,000 participants, they created a global organ damage score (HyperScore) and identified six hypertensive disease phenotypes, demonstrating the model's effectiveness in predicting organ-specific disease progression and survival outcomes. This study suggests that machine learning can enhance hypertension assessment and enable personalized risk management strategies.